Skip to content

Suppressive effect of test food on the postprandial blood sugar level of glucose load -A randomized, double blind, placebo controlled, cross-over study-

Suppressive effect of test food on the postprandial blood sugar level of glucose load -A randomized, double blind, placebo controlled, cross-over study- - Suppressive effect of combination of test food on the postprandial blood sugar level of glucose load

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035381
Enrollment
40
Registered
2019-01-14
Start date
2019-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Sponsors

FANCL Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females 20 to 64 years of age 2) Subjects whose fasting blood sugar levels are less than 126 mg/dL. 3) Subjects whose postprandial blood sugar levels at 120 minutes after the test food glucose load are less than 200 mg/dL.

Exclusion criteria

Exclusion criteria: 1) Subjects who has serious medical history or who had digestive tract resection surgery. 2) Subjects whose HbA1c(NGSP) are more than 6.4% 3) Subjects who routinely use medicine, supplements, FOSHU, and/or health food which affect to result of the study. 4) Subjects who have allergy to the test food or rice. 5) Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating. 6) Heavy use of alcohol or excessive smokers. 7) Subjects who is considered to be inappropriate to attend the present study by the investigator.

Design outcomes

Primary

MeasureTime frame
Area under the curve for postprandial blood sugar level of glucose load

Secondary

MeasureTime frame
Area under the curve for postprandial insulin level and postprandial blood sugar levels of glucose load

Countries

Japan

Contacts

Public ContactKosuke Suzuki

Medical Corporation Jikokai Clinical Trial Division

suzuki-jikoukai@e-mail.jp011-868-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026